Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Surveillance of LIVTENCITY Tablets 200mg (All-Case Investigation)

NCT06577363 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT06577363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06577363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Surveillance of LIVTENCITY Tablets 200mg (All-Case Investigation)
Lead sponsor
Takeda
Phase
Observational
Overall status
Recruiting
Start date
August 28, 2024
Completion date
June 30, 2028
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus (cmv)